Last month, the U.S. government stunned many in the scientific community by canceling nearly $500 million in contracts for mRNA vaccine research.
But according to a Nature report, while the Department of Health and Human Services is pulling back, America’s military continues to bankroll key mRNA vaccine efforts — especially against some of the world’s most dangerous pathogens.
Even as HHS Secretary Robert F. Kennedy Jr. winds down the department’s mRNA commitments, the Department of War is stepping in to keep parts of the research alive.
Among those benefiting is a program targeting Crimean-Congo hemorrhagic fever (CCHF), a tick-borne virus with a fatality rate as high as 40%, Nature reported.
US Military Still Financing mRNA Vaccine Studies
RELATED ARTICLES